156 related articles for article (PubMed ID: 31933993)
1. Evaluation of the correlativity of gender determining region Y-box 4, N-cadherin, CD44 and E-cadherin expression in the prognosis of esophageal squamous cell carcinoma.
Qin Y; Zhao W; Cheng L; Gao J; Bian Z; Wu S; Cheng Z; Tao Y; Ma L
Int J Clin Exp Pathol; 2019; 12(5):1745-1756. PubMed ID: 31933993
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of vasculogenic mimicry, vascular endothelial cadherin and SOX4 in patients with esophageal squamous cell carcinoma.
Qin Y; Zhao W; Cheng L; Wu S; Wu Q; Gao J; Bian Z; Ma L
Int J Clin Exp Pathol; 2019; 12(7):2462-2473. PubMed ID: 31934073
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma.
Zhang M; Li H; Han Y; Wang M; Zhang J; Ma S
Auris Nasus Larynx; 2021 Dec; 48(6):1167-1175. PubMed ID: 34001394
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma.
Zhang M; Li H; Han Y; Wang M; Zhang J; Ma S
Medicine (Baltimore); 2021 Mar; 100(12):e25028. PubMed ID: 33761659
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significances of PLOD2, epithelial-mesenchymal transition markers, and cancer stem cells in patients with esophageal squamous cell carcinoma.
Gong X; Wang A; Song W
Medicine (Baltimore); 2022 Aug; 101(34):e30112. PubMed ID: 36042592
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of sex determining region Y-box 2, E-cadherin, and vimentin in esophageal squamous cell carcinoma.
Li C; Ma YQ
World J Clin Cases; 2022 Sep; 10(27):9657-9669. PubMed ID: 36186174
[TBL] [Abstract][Full Text] [Related]
7. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
8. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
9. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
10. Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakamoto A; Owaki T; Aikou T
J Exp Clin Cancer Res; 2009 Dec; 28(1):158. PubMed ID: 20025748
[TBL] [Abstract][Full Text] [Related]
11. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
[TBL] [Abstract][Full Text] [Related]
12. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
Sato N; Fujishima F; Nakamura Y; Aoyama Y; Onodera Y; Ozawa Y; Ito K; Ishida H; Kamei T; Watanabe M; Sasano H
Hum Pathol; 2018 Oct; 80():113-122. PubMed ID: 29898384
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of MTA1, SOX4 and EZH2 expression in esophageal squamous cell carcinoma.
Liu W; Xia Y; Li M; Abulajiang G; Wang H; Su L; Li C; Shi Y; Zhang W; Xu S; Ma Y
Exp Ther Med; 2021 Jul; 22(1):722. PubMed ID: 34007331
[TBL] [Abstract][Full Text] [Related]
14. TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma.
Dong Y; Fan B; Li M; Zhang J; Xie S; Di S; Jia Q; Gong T
Pathol Res Pract; 2024 Jan; 253():154964. PubMed ID: 38000203
[TBL] [Abstract][Full Text] [Related]
15. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract][Full Text] [Related]
16. Relationship between TWIST expression and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma.
Gao Y; Xuan XY; Zhang HY; Wang F; Zeng QR; Wang ZQ; Li SS
Cell Biol Int; 2012 Jun; 36(6):571-7. PubMed ID: 22360285
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma.
Mahmoudian RA; Gharaie ML; Abbaszadegan MR; Alasti A; Forghanifard MM; Mansouri A; Gholamin M
Mol Cell Biochem; 2021 Jun; 476(6):2465-2478. PubMed ID: 33604811
[TBL] [Abstract][Full Text] [Related]
18. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
Liu B; Li X; Li C; Xu R; Sun X
Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
[TBL] [Abstract][Full Text] [Related]
19. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
20. SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.
Cui XB; Shen YY; Jin TT; Li S; Li TT; Zhang SM; Peng H; Liu CX; Li SG; Yang L; Li N; Hu JM; Jiang JF; Li M; Liang WH; Li Y; Wei YT; Sun ZZ; Wu CY; Chen YZ; Li F
J Transl Med; 2015 Oct; 13():321. PubMed ID: 26444413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]